Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zs Pharma, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zs Pharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Zs Pharma, Inc. since 2005.
The reporting company's ticker symbol is ZSPH. The reporting company's CIK number is 1459266.
The total value of stock buying since 2005 is $17,910,000.
The total value of stock sales since 2005 is $41,022,832.
The total value of stock option exercises since 2005 is $749,121.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2015-12-10||Guillem Alvaro (President)||Option Ex||9,154||10.92||99,998|
|2015-12-09||Keyser D Jeffrey (Chief Operating Officer)||Option Ex||9,154||10.92||99,998|
|2015-12-08||Tomasi Adam (See Remarks)||Option Ex||9,156||10.92||100,020|
|2015-12-08||Smith Cynthia (Chief Commercial Officer)||Option Ex||9,155||10.92||100,009|
|2015-12-08||Alexander Robert (Chief Executive Officer)||Option Ex||17,807||5.62||100,004|
|2015-12-08||Asbury Mark (Chief Legal Officer)||Option Ex||3,478||28.75||99,992|
|2015-08-21||Creech Todd A (Other)||Sale||50,000||49.76||2,488,000|
|2015-08-21||Creech Todd A (Other)||Option Ex||50,000||2.13||106,500|
|2015-08-20||Creech Todd A (Other)||Sale||20,000||50.03||1,000,600|
|2015-08-20||Creech Todd A (Other)||Option Ex||20,000||2.13||42,600|
|2015-06-08||Nohra Guy P (Director)||Sale||11,200||57.53||644,336|
|2015-06-05||Nohra Guy P (Director)||Sale||164,227||57.88||9,505,458|
|2015-06-04||Nohra Guy P (Director)||Sale||88,408||57.46||5,079,923|
|2015-06-03||Nohra Guy P (Director)||Sale||23,189||56.60||1,312,497|
|2015-06-02||Nohra Guy P (Director)||Sale||84,342||56.77||4,788,095|
|2015-06-01||Nohra Guy P (Director)||Sale||72,520||58.00||4,206,160|
|2015-05-29||Nohra Guy P (Director)||Sale||139,561||59.16||8,256,428|
|2014-12-15||Melzer Thomas C. (10% Owner)||Sale||79,444||47.09||3,741,335|
|2014-06-23||Devon Park Associates, Llc (10% Owner)||Buy||160,000||18.00||2,880,000|
|2014-06-23||Novo A/s (Other)||Buy||275,000||18.00||4,950,000|
|2014-06-23||Ostro Marc (Director)||Buy||160,000||18.00||2,880,000|
|2014-06-23||Nohra Guy P (Director)||Buy||200,000||18.00||3,600,000|
|2014-06-23||Champsi Farah (10% Owner)||Buy||200,000||18.00||3,600,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ZSPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zs Pharma, Inc. (symbol ZSPH, CIK number 1459266) see the Securities and Exchange Commission (SEC) website.